A. R. Lemos

发表

Development of lipid nanocapsules encapsulating exenatide for oral delivery in the treatment of type 2 diabetes mellitus

A. R. Lemos, 2019 .

Rationally Designed Potent BMX Inhibitors Reveals Mode of Covalent Binding at the Atomic Level

C. Robinson, A. Koehler, P. Matias, 2020 .

Optimization of TEAD P-Site Binding Fragment Hit into In Vivo Active Lead MSC-4106.

F. Freire, D. Musil, C. Dillon, 2022, Journal of medicinal chemistry.

Production of high‐quality SARS‐CoV‐2 antigens: Impact of bioprocess and storage on glycosylation, biophysical attributes, and ELISA serologic tests performance

J. Demengeot, M. Bergman, P. Alves, 2020, Biotechnology and bioengineering.

Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer

G. Domenici, C. Brito, Maria Raquel Moita, 2021, Cancers.

Structural and biophysical insights into the mode of covalent binding of rationally designed potent BMX inhibitors

C. Robinson, A. Koehler, P. Matias, 2020, RSC chemical biology.

Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors

P. Alves, D. Simão, Gabriela Silva, 2023, Biomolecules.

Development of antibodies against the Notch ligand Delta-Like-1 by phage display with activity against breast cancer cells.

G. Domenici, Joana Sales-Dias, Gabriela Silva, 2021, New biotechnology.

Screening Pyridine Derivatives against Human Hydrogen Sulfide-synthesizing Enzymes by Orthogonal Methods

J. B. Vicente, G. Duburs, L. Saso, 2019, Scientific Reports.